Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengyang Shiyiwei Pill
- Development stage
- Preclinical
- Lead developer
- Inner Mongolia Furui Medical Science
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shengyang Shiyiwei Pill (SYP) is a traditional Chinese medicine (TCM) formulation, often associated with Mongolian medical traditions, used primarily for the treatment of liver diseases, including hepatocellular carcinoma (HCC) and its complications such as malignant ascites. It is a multi-component herbal product composed of eleven ingredients designed to provide a multi-targeted therapeutic approach. Research indicates that SYP can enhance the efficacy of anti-angiogenic agents like bevacizumab by promoting ferroptosis in HCC cells and modulating the tumor microenvironment. It is typically used as an adjunctive therapy in China to improve clinical outcomes and overcome resistance to standard-of-care targeted treatments in oncology.
- Brand names
- Shengyang Shiyiwei Pill
- Other names
- Shengyang Shiyiwei Wan升阳十一味丸
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)ALB (Human serum albumin)EGFR (Epidermal growth factor receptor)G6PD (Glucose-6-phosphate dehydrogenase)GPX4 (Glutathione peroxidase 4)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Shengyang Shiyiwei Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shengyang Shiyiwei Pill.